JOSHUA RIVERS: Open Payments
NPI 1639599483 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 80 payments from 14 companies in 2025. Trend: 2023 $730 · 2024 $1,532 · 2025 $1,735
Food & beverage: $1,735
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $765 |
| Madrigal Pharmaceuticals | 7 | $263 |
| Gilead Sciences, Inc. | 3 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $64 |
| Aimmune Therapeutics, Inc. | 4 | $61 |
| Lilly USA, LLC | 2 | $51 |
| Ardelyx, Inc. | 3 | $48 |
Products named: REZDIFFRA, SKYRIZI, LINZESS, RINVOQ, CREON, Livdelzi, DUPIXENT, ENTYVIO.
Industry payments across AL — which companies pay providers there.
